52
Participants
Start Date
August 31, 2007
Primary Completion Date
August 31, 2014
Study Completion Date
August 31, 2014
Sunitinib
Vanderbilt University, Nashville
Washington University in St. Louis, St Louis
Massachusetts General Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Dana-Farber Cancer Institute, Boston
Collaborators (1)
Beth Israel Deaconess Medical Center
OTHER
Massachusetts General Hospital
OTHER
Pfizer
INDUSTRY
Dana-Farber Cancer Institute
OTHER